The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6155-6168

Bentham Science Publishers

Access to resources Recommend Favorite

Novel peptides targeting the hepatocyte growth factor receptor c-Met for the treatment of cancer

By Michaud Neil R  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 621-625

Informa Healthcare

Access to resources Recommend Favorite

Development of c-MET pathway inhibitors

By Liu Xiangdong   Newton Robert C   Scherle Peggy A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1225-1241

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Old Drugs Learn New Tricks: Advances and Applications for Drug Repurposing

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 30, 2016-12 ,pp. : 3627-3628

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria   Karrila Anna   Nordberg Janne   Grénman Reidar   Elenius Klaus  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite